Publication:
Appropriateness of using tests for blood glucose and diabetic complications in clinical practice: Experiences in a hospital in Thailand

0
0

Issued Date

2018

Resource Type

Article

File Type

application/pdf

ISSN

12341010

DOI

10.12659/MSM.911216

Other identifier(s)

2-s2.0-85054896326

Rights Holder(s)

Scopus

Bibliographic Citation

Medical Science Monitor. Vol 24, (2018), p.7382-7386

Suggested Citation

Lekskulchai V. Appropriateness of using tests for blood glucose and diabetic complications in clinical practice: Experiences in a hospital in Thailand. Medical Science Monitor. Vol 24, (2018), p.7382-7386. doi:10.12659/MSM.911216 Retrieved from: https://hdl.handle.net/20.500.14740/5814

Title

Appropriateness of using tests for blood glucose and diabetic complications in clinical practice: Experiences in a hospital in Thailand

Author(s)

Lekskulchai V.

Abstract

Background: This study aimed to evaluate how the tests for blood glucose (BG) and diabetic complications have been utilized in a hospital in Thailand. Material/Methods: Patient medical records having the results of BG, HbA1c, and/or urine microalbumin presented and the records of DM patients having the results of serum lipids, serum LDL-C, and/or serum creatinine presented were selected. The data of diagnosis, ordered tests, and testing results in these records were extracted for evaluation. Results: This study recruited 1066 patients diagnosed with DM and 3081 patients diagnosed with other diseases. Point-of-care testing (POCT) for BG was repeatedly used in 371 non-DM cases; most of its results were normal. The results of BG and HbA1c were often used together. There was a good relationship between them, and these test results indicated poor glycemic control in 58% of DM cases. In non-DM cases, the test results agreed, indicating normoglycemia in 17.32%, pre-diabetes in 20.47%, and diabetes in 21.78%. To prevent diabetic nephropathy, serum creatinine was frequently used, whereas urine microalbumin, the recommended test, was underutilized. The result of LDL-C from both direct measurement and calculation were used; however, based on the same guidelines, the results of measured LDL-C indicated risk of cardiovascular diseases in a higher percentage of DM cases than did the results of calculated LDL-C. Conclusions: The use of POCT for BG in hospitalized patients may be inappropriate. The utilization of urine microalbumin should be promoted to effectively prevent diabetic nephropathy. © Med Sci Monit, 2018.

Subject(s)

Albumin
 Creatinine
 Hemoglobin A1c
 Lipid
 Microalbumin
 Unclassified drug
 Creatinine
 Glycosylated hemoglobin
 Article
 Blood glucose monitoring
 Cardiovascular disease
 Clinical practice
 Diabetes mellitus
 Diabetic nephropathy
 Diagnostic test
 Diagnostic test accuracy study
 Glucose blood level
 Human
 Hyperglycemia
 Hypoglycemia
 Kidney failure
 Low density lipoprotein cholesterol level
 Major clinical study
 Point of care testing
 Thailand
 Urinalysis
 Adult
 Albuminuria
 Analysis
 Blood
 Diabetic complication
 Diabetic nephropathy
 Female
 Glucose blood level
 Glucose tolerance test
 Hospital
 Hyperglycemia
 Male
 Metabolism
 Middle aged
 Procedures
 Trends
 Urine
 Adult
 Albuminuria
 Blood Glucose
 Creatinine
 Diabetes Complications
 Diabetic Nephropathies
 Female
 Glucose Tolerance Test
 Glycated Hemoglobin A
 Hospitals
 Humans
 Hyperglycemia
 Male
 Middle Aged
 Point-of-Care Testing
 Thailand

View online Resources

Research Projects

Organizational Units

Journal Issue

URI

https://hdl.handle.net/20.500.14740/5814

Collections

Scopus: Year 1983-2021

Endorsement

Review

Supplemented By

Referenced By